URGN Overview
Upcoming Projects (URGN)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (URGN)
-
A Second Look: Highlighting UroGen Pharma Ltd.'s Breakthrough: Insights into the ENVISION Trial of UGN-102 for LG-IR-NMIBC
Ticker: URGN
Executed On: Jun 27, 2024 at 04:00 PM EDT -
Highlighting UroGen Pharma Ltd.'s Breakthrough: Insights into the ENVISION Trial of UGN-102 for LG-IR-NMIBC
Ticker: URGN
Executed On: Jun 27, 2024 at 12:30 PM EDT -
A second look at novel therapeutics in development for NMIBC, including; Cretostimogene, TAR-200, TAR-210 Erdafitinib Intravesical Delivery System, and UGN-102
Tickers: CGON, JNJ, URGN
Executed On: Jun 25, 2024 at 11:00 AM EDT -
Understanding the Potential of UGN-102 in Treating Recurrent Low Grade Intermediate Risk Bladder Cancer If Approved
Ticker: URGN
Executed On: Mar 27, 2024 at 03:00 PM EDT
Free Project -
A second look: Discussing Urogen's UGN-102 and its potential in LG-IR-NMIBC following the ATLAS and ENVISION top line
Ticker: URGN
Executed On: Aug 22, 2023 at 06:00 PM EDT -
Discussing Urogen's UGN-102 and its potential in LG-IR-NMIBC following the ATLAS and ENVISION top line
Ticker: URGN
Executed On: Aug 09, 2023 at 12:30 PM EDT
Upcoming & Overdue Catalysts (URGN)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (URGN)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
